Get started
Author

Xinyu Luan

ORCID: 0009-0007-7346-9968
Observed ORCID: 0009-0007-7346-9968
OpenAlex ID: A5103071656
Single‐cell and spatial transcriptomics reveal POSTN + cancer‐associated fibroblasts correlated with immune suppression and tumour progression in non‐small cell lung cancer
2023 · Chao Chen, Qiang Guo, et al. · Clinical and Translational Medicine · 159
Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
2023 · Liusheng Wu, Qi Liu, et al. · Biomedicines · 133
PDF
Tumor Cell-Derived Exosomal miR-770 Inhibits M2 Macrophage Polarization via Targeting MAP3K1 to Inhibit the Invasion of Non-small Cell Lung Cancer Cells
2021 · Jixian Liu, Ruixing Luo, et al. · Frontiers in Cell and Developmental Biology · 55
PDF
Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis
2020 · Jixian Liu, Guangxian Mao, et al. · Journal of Cancer Research and Clinical Oncology · 18
TFAP2A Promotes Cell Progression and Suppresses Ferroptosis in Lung Adenocarcinoma via Activating Transcription of CST1
2024 · Xinyu Luan, Xuxing Peng, et al. · Journal of Biochemical and Molecular Toxicology · 9
PDF
Circ_0020123 promotes non‐small cell lung cancer progression via miR ‐146a‐5p mediated regulation of EIF4G2 expression
2023 · Zichun Wei, Jixian Liu, et al. · Thoracic Cancer · 4
LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression
2025 · Xinyu Luan, Xuxing Peng, et al. · Journal of Immunology Research · 3
YY1‐Upregulated MTHFD2 Drives Non‐Small Cell Lung Cancer Progression Through the Regulation of LRRK2
2025 · Zichun Wei, Jixian Liu, et al. · Journal of Biochemical and Molecular Toxicology · 2
PDF
Enhancing pathological complete response prediction in stage II/III breast cancer: the role of radiomics signatures of MRI and its association with tumor microenvironment heterogeneity
2026 · Chao Zheng, Jiexin Sheng, et al. · BMC Medical Imaging
RS8a Segmentectomy by 3D Navigation
2023 · Jixian Liu, Xinyu Luan · Springer eBooks
LS9 + LS10 Segmentectomy by 3D Navigation
2023 · Jixian Liu, Xinyu Luan · Springer eBooks
Mutational distinction between adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma in lung cancer patients with multiple tumors.
2020 · Jixian Liu, Yingmei Li, et al. · Journal of Clinical Oncology
Works count: 12
Citation count: 383
H-index: 5
I10-index: 4
Year
Topic
Type